← Browse by Condition
Medical Condition

sleep apnea obstructive

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for sleep apnea obstructive sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — sleep apnea obstructive Clinical Trials

How many clinical trials are currently recruiting for sleep apnea obstructive?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for sleep apnea obstructive, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for sleep apnea obstructive?
sleep apnea obstructive research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a sleep apnea obstructive clinical trial?
Eligibility criteria for sleep apnea obstructive trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
University of Pennsylvania 1 trial
Vivek Jain 1 trial
Loma Linda University 1 trial
Peking University First Hospital 1 trial
University of California, San Diego 1 trial

Recruiting Clinical Trials

NCT06789770
Recruiting

Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep

Enrollment
50 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT03860233 Phase 1
Recruiting

Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine

Enrollment
40 pts
Location
United States
Sponsor
Vivek Jain
View Trial →
NCT05575401
Recruiting

Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy

Enrollment
160 pts
Location
United States
Sponsor
Loma Linda University
View Trial →
NCT06573372
Recruiting

Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea

Enrollment
295 pts
Location
China
Sponsor
Peking University First Hospit...
View Trial →
NCT04875364 Phase 2
Recruiting

Do Endotypes Predict Response and Sequelae in OSA Patients

Enrollment
200 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology